The therapeutic landscape is shifting—and biomarkers are at the center of this transformation. In this exclusive session, we’ll spotlight high-impact protein targets including FOLR1, HER2, Claudin ...

Protein therapeutics play a pivotal role across the modern healthcare landscape, offering treatment options for a wide range of indications. To meet the increased demand for these therapies, it is ...

Across the biotech industry, the demand for accelerated time to clinic, operational precision, and robust scalability has never been more critical. Developers face the complexity of solving a growing ...